Sept 30 (Reuters) – The U.S. Food and Drug Administration has approved Novartis' oral treatment for patients with type of chronic inflammatory skin disease, the company said on Tuesday. (Reporting by Siddhi Mahatole in Bengaluru; Editing by Sahal Muhammed)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Siddharth Cavale -In 2020, as COVID-19 raged, John Furner - then chief of Walmart's…
By Divya Rajagopal TORONTO -The board of Canada's Barrick Mining has raised the possibility of…
(Reuters) -Bitcoin, the world's largest cryptocurrency by market value, was down by 1.59% at $93,684…
By Timour Azhari and Mohammed Benmansour RIYADH (Reuters) -Cristiano Ronaldo. Naomi Campbell. Sofia Vergara. And…
By Lisa Richwine and Dawn Chmielewski LOS ANGELES (Reuters) -Walt Disney signaled on Thursday it…
DUBAI (Reuters) -Airbus looks set to beat Boeing to the lion's share of a major…